5VM

5AM Venture Management Portfolio holdings

AUM $260M
This Quarter Return
-24.26%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
AUM
$458M
AUM Growth
+$458M
Cap. Flow
+$86.4M
Cap. Flow %
18.88%
Top 10 Hldgs %
83.75%
Holding
19
New
2
Increased
1
Reduced
1
Closed

Top Sells

1
RLYB icon
Rallybio
RLYB
$1.47M

Sector Composition

1 Healthcare 99.21%
2 Financials 0.79%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PEAR
1
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$94.1M 20.55% 18,631,771
CINC
2
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$76.1M 16.62% +4,337,646 New +$76.1M
TRDA icon
3
Entrada Therapeutics
TRDA
$208M
$41.4M 9.04% 4,408,379
VOR icon
4
Vor Biopharma
VOR
$250M
$38.4M 8.39% 6,361,723
RLYB icon
5
Rallybio
RLYB
$22.4M
$27.8M 6.07% 3,980,724 -210,000 -5% -$1.47M
ARVN icon
6
Arvinas
ARVN
$568M
$26.9M 5.88% 400,000
SCPH icon
7
scPharmaceuticals
SCPH
$295M
$21.8M 4.75% 3,831,474
AKUS
8
DELISTED
Akouos, Inc. Common Stock
AKUS
$19.6M 4.29% 4,135,784
CRNX icon
9
Crinetics Pharmaceuticals
CRNX
$2.92B
$18.9M 4.13% 862,286
IMPL
10
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$18.4M 4.01% 2,884,791
ISEE
11
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$17.3M 3.78% 1,027,874 +384,626 +60% +$6.47M
IDYA icon
12
IDEAYA Biosciences
IDYA
$2.15B
$15.6M 3.42% 1,398,066
QTTB icon
13
Q32 Bio
QTTB
$20.9M
$13.8M 3.01% 4,535,919
RNA icon
14
Avidity Biosciences
RNA
$5.99B
$7.21M 1.58% 390,555
JANX icon
15
Janux Therapeutics
JANX
$1.37B
$6.4M 1.4% 446,266
COGT icon
16
Cogent Biosciences
COGT
$1.69B
$5.33M 1.16% +711,412 New +$5.33M
CABA icon
17
Cabaletta Bio
CABA
$133M
$4.19M 0.92% 2,064,263
FVAM
18
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
$3.6M 0.79% 365,126
CDTX icon
19
Cidara Therapeutics
CDTX
$1.66B
$945K 0.21% 1,134,511